Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Peter Matthew Kennedy de Blank, MD |
Children's Tumor Foundation Ne |
The Children's Tumor Foundation |
CTF, DeBlank, P. |
1/1/22-12/31/22 |
$150 |
Rajaram Nagarajan, MD |
Research Into Visual Endpoints |
National Institutes of Health (NIH)/Vanderbilt University Medical Center |
VUMV67585 |
8/1/21-7/31/22 |
$4,000 |
Peter Matthew Kennedy de Blank, MD |
NF110: Open-label, Phase 2 Cli |
Department of Defense/The Board of Trustees of the University |
000516840-T002-SC004 |
4/23/20-8/15/21 |
$4,340 |
Kaylin G Earnest, PHD |
Training grant |
National Institutes of Health (NIH)/University of Cincinnati |
1015348 |
9/1/20-8/31/21 |
$5,410 |
Karen C Burns, MD |
Fertility Status Assessment Am |
National Institutes of Health (NIH)/Emory University |
A567559 |
9/15/21-7/31/22 |
$5,852 |
James Geller, MD |
Study Chair |
National Institutes of Health (NIH)/Public Health Institute |
AR03451 |
3/1/21-2/28/22 |
$7,833 |
James Geller, MD |
Study Chair AREN 1721 2021 |
National Institutes of Health (NIH)/Public Health Institute |
AR03450 |
3/1/21-2/28/22 |
$7,833 |
Robin E Norris, MD-MPH |
NCTN Renal Committee Retreat |
National Institutes of Health (NIH)/Public Health Institute |
AR04978 |
3/1/21-2/28/22 |
$8,000 |
Peter Matthew Kennedy de Blank, MD |
Biomarker, Imaging and Quality |
National Institutes of Health (NIH)/Public Health Institute |
AR04810 |
3/1/21-2/28/22 |
$8,080 |
Christine L Phillips, MD |
Asparaginase premedication, hy |
Childrens Hospital of Orange County |
Phillips, C, CHOC |
12/1/21-11/30/22 |
$8,470 |
Maureen O'Brien, MD |
Scientific Advisor Board Service |
Alex's Lemonade Stand Foundation |
O'Brien, Maureen ALS |
12/1/21-11/30/22 |
$10,000 |
Lisa Marie Privette Vinnedge, PHD |
Functional Role of DEK in Alzh |
Life Sciences Research Foundation/University of Cincinnati |
LIFE FND 2019 |
11/1/20-10/31/22 |
$10,500 |
Teresa S. Latham |
SU2C Catalyst Grant |
Stand Up to Cancer/Nationwide Children's Hospital |
SU2C 6147 |
7/1/20-8/31/21 |
$12,375 |
Trent Hummel, MD |
Targeting epigenetic dysregula |
Stand Up to Cancer/Dana Farber Cancer Institute |
6332101 |
1/1/22-12/31/22 |
$13,567 |
Biplab DasGupta, PHD |
Therapeutic resistance and agg |
National Institute for Health Research/University of Cincinnati |
013734-00002 |
7/1/21-6/30/22 |
$14,324 |
James Geller, MD |
Study Chair |
National Institutes of Health (NIH)/Public Health Institute |
AR03426 |
3/1/21-2/28/22 |
$15,665 |
William Seibel, PHD |
Structure, function, and modul |
National Institutes of Health (NIH)/The University of Chicago |
AWD102456SUB00000571 |
9/30/21-7/31/22 |
$18,268 |
Peter Matthew Kennedy de Blank, MD |
CHOP-COG ACN1833 |
Matthew Larson Pediatric Brain Tumor Fdn/Children's Hospital of Philadelphia |
ACNS1833 |
8/1/21-7/31/26 |
$18,958 |
Biplab DasGupta, PHD |
Co-targeting S6 and TAM kinas |
National Institutes of Health (NIH)/University of Cincinnati |
12653-002 |
12/1/21-11/30/22 |
$19,467 |
Rajaram Nagarajan, MD |
Research Into Visual Endpoints |
National Institutes of Health (NIH)/Vanderbilt University Medical Center |
VUMV67585 |
8/1/21-7/31/22 |
$22,397 |
Peter Matthew Kennedy de Blank, MD |
Study Chair |
National Institutes of Health (NIH)/Public Health Institute |
AR03413 |
3/1/21-2/28/22 |
$23,498 |
Maureen O'Brien, MD |
O'Brien PHI-COG Study Chair AALL1732 2021 |
National Institutes of Health (NIH)/Public Health Institute |
: AR03402 |
3/1/21-2/28/22 |
$23,499 |
Robin E Norris, MD-MPH |
A Phase 2 Randomized Trial of |
National Institutes of Health (NIH)/Children's Hospital Los Angeles |
T2020-003 |
9/14/21-8/31/26 |
$26,000 |
Robin E Norris, MD-MPH |
Norris PHI-COG Associate Medic |
National Institutes of Health (NIH)/Public Health Institute |
AR03186 |
3/1/21-2/28/22 |
$31,330 |
Robin E Norris, MD-MPH |
PHI-COG PCR Work Order 2021 |
National Institutes of Health (NIH)/Public Health Institute |
Norris_R._PHI/NIH |
3/1/21-2/28/25 |
$34,004 |
Robin E Norris, MD-MPH |
PHI-COG NCTN Work Order 2021 |
National Institutes of Health (NIH)/Public Health Institute |
U10CA180886 |
3/1/21-2/28/25 |
$34,004 |
Brian Keith Turpin, DO |
SARC038: A Phase 2 Study of R |
Sarcoma Alliance for Res through Collabo |
SARC038 |
10/1/21-9/30/26 |
$36,250 |
Robin E Norris, MD-MPH |
Norris PHI-COG PEP-CTN WLI Core Work Order |
National Institutes of Health (NIH)/Public Health Institute |
AR06748 |
8/1/21-7/31/23 |
$40,627 |
Joseph Pressey, MD |
Norris PHI-COG PEP-CTN PCR Work Order |
National Institutes of Health (NIH)/Public Health Institute |
AR06748 |
8/1/21-7/31/23 |
$40,779 |
John P Perentesis, MD |
A Phase I study of Venetoclax |
Conquer Cancer Foundation/Michigan State University |
RC111290 CHMC |
7/1/20-6/30/22 |
$46,500 |
Robin E Norris, MD-MPH |
Norris PHI-COG NCORP PCR Work Order 2021 |
National Institutes of Health (NIH)/Public Health Institute |
UG1CA189955-08 |
8/1/21-7/31/25 |
$47,504 |
Robin E Norris, MD-MPH |
Norris PHI-COG NCORP PCR Work Order 2021 |
National Institutes of Health (NIH)/Public Health Institute |
UG1CA189955-08 |
8/1/21-7/31/25 |
$47,504 |
Natasha Pillay-Smiley, DO |
The Pediatric Brain Tumor Cons |
National Institutes of Health (NIH)/St Jude's Children's Hospital |
110068220-7998047 |
4/1/21-3/31/22 |
$49,920 |
Natasha Pillay-Smiley, DO |
The Pediatric Brain Tumor Cons |
National Institutes of Health (NIH)/St Jude's Children's Hospital |
110068210-7947557 |
4/1/21-3/31/22 |
$49,920 |
Alexandra Power-Hays, MD |
ADAPT- Alternate Dosing And Pr |
American Society of Hematology |
ASH_Power Hays |
7/1/21-6/30/22 |
$50,000 |
Natasha Pillay-Smiley, DO |
Understanding Chemotherapy Failure in AML: Resistance Mechanisms to a Nanoparticle Chemotherapy Delivery System |
National Institutes of Health (NIH)/Children's Hospital of Philadelphia |
U10CA180886 |
3/1/20-2/28/21 |
$50,000 |
John P Perentesis, MD |
Investigating the role of ovar |
Cancer Free Kids |
Absalon/Grimes_Cance |
12/1/17-12/31/21 |
$50,000 |
Lisa Marie Privette Vinnedge, PHD |
COG Autopsy Initiative |
Cancer Free Kids |
Johnstone, M., CFK |
7/1/20-6/30/23 |
$50,000 |
Biplab DasGupta, PHD |
One carbon and nucleotide meta |
Cancer Free Kids |
CFK, Dasgupta, D. |
1/1/22-6/30/23 |
$50,000 |
Biplab DasGupta, PHD |
Therapeutic Blockade of Metabo |
Team Connor Childhood Cancer Foundation |
TCCCF, Dasgupta, B. |
1/1/22-12/31/22 |
$50,000 |
Emily L Duderstadt, PHD |
Training Grant |
National Institutes of Health (NIH)/University of Cincinnati |
1016448 |
9/1/21-2/11/22 |
$52,704 |
Natasha Pillay-Smiley, DO |
PBTC-060: A Pilot Study of Saf |
National Institutes of Health (NIH)/St Jude's Children's Hospital |
Pillay-Smiley, St Ju |
3/1/22-2/28/27 |
$59,320 |
Natasha Pillay-Smiley, DO |
Phase 1 Trial of Autologous HE |
National Institutes of Health (NIH)/St Jude's Children's Hospital |
PBTC-059 |
1/1/22-12/31/26 |
$59,320 |
John P Perentesis, MD |
Children's Oncology Group Pedi |
National Institutes of Health (NIH)/Children's Hospital of Philadelphia |
SUB23 01 |
8/1/19-7/31/20 |
$60,001 |
Lynn H Lee, MD |
Targeting MBNL1-mediated alter |
St. Baldrick's Foundation |
AwardID: 638749 |
7/1/21-6/30/22 |
$63,190.51 |
Brenton Francisco, MD |
A multicenter open-label study |
Hyundai Hope on Wheels |
HHOW |
7/1/21-6/30/22 |
$100,000 |
Brian D Weiss, MD |
A multicenter open-label study |
Advanced Accelerator Applications, Inc. |
CAAA601A32201 |
8/1/21-7/30/26 |
$86,404 |
Alexandra Power-Hays, MD |
Alternative Dosing And Prevent |
Doris Duke Charitable Foundation |
2021097 |
7/1/21-6/30/22 |
$110,000 |
Susanne Wells, PHD |
P50 SPORE Pilot project #4 Max |
National Institutes of Health (NIH)/University of Cincinnati Cancer Center |
4600003138 |
4/1/21-11/30/22 |
$106,540 |
LaQuita M Jones, DO |
Kinase-independent mechanism o |
St. Baldrick's Foundation |
839526 |
7/1/21-6/30/22 |
$110,000 |
Francis R LeBlanc, MD-PHD |
Defining genetic and metabolic |
National Institutes of Health (NIH)/Cornell University |
215518-2 |
7/1/21-6/30/22 |
$119,880 |
Peter Matthew Kennedy de Blank, MD |
The Neurofibromatosis Clinical |
Department of Defense Army/University of Alabama-Birmingham |
000516840-SC004 |
8/15/21-8/14/22 |
$128,235 |
Susanne Wells, PHD |
Defining genetic and metabolic |
National Institutes of Health (NIH)/University of Cincinnati |
012828-002 |
4/1/21-3/31/22 |
$170,000 |
Lynn H Lee, MD |
Targeting MBNL1-mediated alter |
National Institutes of Health (NIH) |
K08CA237753 |
3/1/22-2/28/23 |
$196,112 |
Biplab DasGupta, PHD |
Targeting Purine Synthesis and |
The Cure Starts Now Foundation |
CSNF_Dasgupta, B. |
10/1/21-9/30/22 |
$200,000 |
Lisa Marie Privette Vinnedge, PHD |
Mechanisms coupling DEK to oncogenesis |
National Institutes of Health (NIH) |
R01CA218072 |
2/1/22-1/31/23 |
$327,341 |
Susanne Wells, PHD |
Strenghening epidermal defense |
National Institutes of Health (NIH) |
R01CA228113 |
12/1/21-11/30/22 |
$334,853 |
Susanne Wells, PHD |
New activities of the human DE |
National Institutes of Health (NIH) |
R01CA239605 |
12/1/21-11/30/22 |
$355,127 |
Susanne Wells, PHD |
FA pathway activities in norma |
National Institutes of Health (NIH) |
R01CA223790 |
8/1/21-7/31/22 |
$363,713 |
Biplab DasGupta, PHD |
Bystander gene deletions in ca |
National Institutes of Health (NIH) |
R01NS114074 |
12/1/21-11/30/22 |
$435,338 |
Biplab DasGupta, PHD |
Mechanisms of Biguanide Sensit |
National Institutes of Health (NIH) |
R01NS099162 |
5/1/22-4/30/23 |
$504,183 |
Trent Hummel, MD |
International Diffuse Intrinsi |
The Cure Starts Now Foundation |
Dewire, DIPG |
12/10/20-12/9/21 |
$1,508,203 |
Total Annual Grant Award Dollars |
$6,497,292.51 |